These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 30803906)

  • 1. Considerations on "Impact of ABO-incompatibility on hepatocellular carcinoma recurrence after living donor liver transplantation".
    Gianardi D; Ghinolfi D; Guadagni S; Morelli L
    Eur J Surg Oncol; 2019 Apr; 45(4):715-716. PubMed ID: 30803906
    [No Abstract]   [Full Text] [Related]  

  • 2. Reply to: Considerations on "Impact of ABO-incompatibility on hepatocellular carcinoma recurrence after living donor liver transplantation".
    Kim SH
    Eur J Surg Oncol; 2019 Apr; 45(4):717-718. PubMed ID: 30803907
    [No Abstract]   [Full Text] [Related]  

  • 3. Impact of ABO-incompatibility on hepatocellular carcinoma recurrence after living donor liver transplantation.
    Kim SH; Lee EC; Na BG; Park SJ
    Eur J Surg Oncol; 2019 Feb; 45(2):180-186. PubMed ID: 30243467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term recurrence-free survival after liver transplantation from an ABO-incompatible living donor for treatment of hepatocellular carcinoma exceeding Milano criteria in a patient with hepatitis B virus cirrhosis: a case report.
    Nakamura Y; Hama K; Iwamoto H; Yokoyama T; Kihara Y; Konno O; Jojima Y; Shimazu M
    Transplant Proc; 2012 Mar; 44(2):565-9. PubMed ID: 22410070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved results of a surgical resection for the recurrence of hepatocellular carcinoma after living donor liver transplantation.
    Taketomi A; Fukuhara T; Morita K; Kayashima H; Ninomiya M; Yamashita Y; Ikegami T; Uchiyama H; Yoshizumi T; Soejima Y; Shirabe K; Maehara Y
    Ann Surg Oncol; 2010 Sep; 17(9):2283-9. PubMed ID: 20204531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between recurrences and immunosuppression on living donor liver transplantation for hepatocellular carcinoma.
    Miyagi S; Kawagishi N; Sekiguchi S; Akamatsu Y; Sato K; Takeda I; Kobayashi Y; Tokodai K; Fujimori K; Satomi S
    Transplant Proc; 2012 Apr; 44(3):797-801. PubMed ID: 22483499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Higher Bilirubin Levels of Healthy Living Liver Donors Are Associated With Lower Posttransplant Hepatocellular Carcinoma Recurrence.
    Han S; Yang JD; Sinn DH; Ko JS; Kim JM; Shin JC; Son HJ; Gwak MS; Joh JW; Kim GS
    Transplantation; 2016 Sep; 100(9):1933-8. PubMed ID: 27362316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical analysis of patients with hepatocellular carcinoma recurrence after living-donor liver transplantation.
    Na GH; Hong TH; You YK; Kim DG
    World J Gastroenterol; 2016 Jul; 22(25):5790-9. PubMed ID: 27433092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome of hepatocellular carcinoma treated by liver transplantation: comparison of living donor and deceased donor transplantation.
    Li C; Wen TF; Yan LN; Li B; Yang JY; Wang WT; Xu MQ; Wei YG
    Hepatobiliary Pancreat Dis Int; 2010 Aug; 9(4):366-9. PubMed ID: 20688599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ABO-incompatible adult living donor liver transplantation for hepatocellular carcinoma.
    Matsuno N; Iwamoto H; Nakamura Y; Hama K; Kihara Y; Konno O; Jojima Y; Akashi I; Mijiti A; Ashizawa T; Nagao T
    Transplant Proc; 2008 Oct; 40(8):2497-500. PubMed ID: 18929778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Living donor liver transplantation versus deceased donor liver transplantation for hepatocellular carcinoma: comparable survival and recurrence.
    Sandhu L; Sandroussi C; Guba M; Selzner M; Ghanekar A; Cattral MS; McGilvray ID; Levy G; Greig PD; Renner EL; Grant DR
    Liver Transpl; 2012 Mar; 18(3):315-22. PubMed ID: 22140013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Living-donor liver transplantation associated with higher incidence of hepatocellular carcinoma recurrence than deceased-donor liver transplantation.
    Park MS; Lee KW; Suh SW; You T; Choi Y; Kim H; Hong G; Yi NJ; Kwon CH; Joh JW; Lee SK; Suh KS
    Transplantation; 2014 Jan; 97(1):71-7. PubMed ID: 24056623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Living donor liver transplantation versus deceased donor liver transplantation for hepatocellular carcinoma: a meta-analysis.
    Liang W; Wu L; Ling X; Schroder PM; Ju W; Wang D; Shang Y; Kong Y; Guo Z; He X
    Liver Transpl; 2012 Oct; 18(10):1226-36. PubMed ID: 22685095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Living donor liver transplantation for recurrent hepatocellular carcinoma.
    Liu C; Frilling A; Sotiropoulos GC; Weber F; Nadalin S; Malago M; Broelsch CE
    Transpl Int; 2005 Jul; 18(7):889. PubMed ID: 15948872
    [No Abstract]   [Full Text] [Related]  

  • 15. Salvage live donor liver transplantation for a second recurrence of hepatocellular carcinoma.
    Sotiropoulos GC; Treckmann JW; Molmenti EP; Schmitz KJ; Cicinnati VR; Paul A; Broelsch CE; Malagó M
    Transpl Int; 2008 Feb; 21(2):182-5. PubMed ID: 17971034
    [No Abstract]   [Full Text] [Related]  

  • 16. Living-donor liver transplantation for hepatocellular carcinoma.
    Kaihara S; Kiuchi T; Ueda M; Oike F; Fujimoto Y; Ogawa K; Kozaki K; Tanaka K
    Transplantation; 2003 Feb; 75(3 Suppl):S37-40. PubMed ID: 12589138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study of living and deceased donor liver transplantation as a treatment for hepatocellular carcinoma.
    Ninomiya M; Shirabe K; Facciuto ME; Schwartz ME; Florman SS; Yoshizumi T; Harimoto N; Ikegami T; Uchiyama H; Maehara Y
    J Am Coll Surg; 2015 Mar; 220(3):297-304.e3. PubMed ID: 25617912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrent hepatocellular carcinoma after living donor liver transplantation: a preventable problem or an acceptable risk?
    Sonnenday CJ
    Ann Surg Oncol; 2010 Sep; 17(9):2262-3. PubMed ID: 20431956
    [No Abstract]   [Full Text] [Related]  

  • 19. Prognostic importance of the gross classification of hepatocellular carcinoma in living donor-related liver transplantation.
    Shirabe K; Aishima S; Taketomi A; Soejima Y; Uchiyama H; Kayashima H; Ninomiya M; Mano Y; Maehara Y
    Br J Surg; 2011 Feb; 98(2):261-7. PubMed ID: 21072849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A revised scoring system utilizing serum alphafetoprotein levels to expand candidates for living donor transplantation in hepatocellular carcinoma.
    Yang SH; Suh KS; Lee HW; Cho EH; Cho JY; Cho YB; Kim IH; Yi NJ; Lee KU
    Surgery; 2007 May; 141(5):598-609. PubMed ID: 17462459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.